– A Breakthrough for Cancer Treatment in Latin America
The 63rd Annual Conference of the Particle Therapy Cooperative Group (PTCOG 63), organized by Kenes Group, will take place June 2–7, 2025, in Buenos Aires, gathering leading experts in particle therapy. This year’s event coincides with a major regional milestone: the launch of Argentina’s first Proton Therapy Center (CeArP – Centro Argentino de Protonterapia), a flagship project advancing cancer treatment and research in Latin America.
CeArP will be the first proton therapy center in Latin America, marking a significant leap in medical innovation. Equipped with the Proteus Plus system, featuring Pencil Beam Scanning and IMPT, it will offer cutting-edge, highly precise cancer treatments while serving as a hub for research and development.
“The opening of Argentina’s first Particle Therapy Center marks a significant milestone for cancer treatment in Latin America. The first proton therapy center in South America reflects the commitment of the region to advancing medical innovation and expanding access to cutting-edge therapies. As the global community gathers for PTCOG 63 in Buenos Aires, we celebrate this important step forward in harnessing particle therapy to improve patient outcomes worldwide.”
— Prof. Marco Durante, Ph.D., PTCOG President
CeArP: Transforming Cancer Treatment in Latin America
A collaboration between CNEA, UBA, IBA, and INVAP, CeArP is set to redefine cancer treatment in the region.
Unlike conventional radiotherapy, proton therapy minimizes damage to healthy tissues, making it ideal for tumors in critical areas like the brain, head and neck, and lungs, as well as for pediatric patients who are highly sensitive to radiation side effects.
“The Argentine Proton Therapy Center, the first of its kind in Latin America, will become a regional reference for clinical and scientific research in particle therapy, being associated with prestigious medical and technological institutions known for their strong academic, scientific, and technological achievements: the National Atomic Energy Commission, the Roffo Cancer Institute of the University of Buenos Aires, and the Garrahan Pediatric Hospital.”
— Gustavo A. Santa Cruz, PTCOG 63 Local Organizing Committee (LOC)
At CeArP’s core is the C230 cyclotron, a 230-tonne particle accelerator installed within a radiation-shielded bunker.
“This is a very important milestone because the cyclotron is the main machine of the Argentine Center for Proton Therapy. Gantries will be installed in the coming days, which are the structures through which proton beams are directed to the patients. We estimate that the first tests could start in the second half of 2025.”
— Luis Rovere, CNEA Vice President
The 8,000-square-meter facility, located next to the Nuclear Diagnosis Centre Foundation (FCDN) and across from the Ángel H. Roffo Institute of Oncology, will serve both clinical and research purposes. It will also feature LAIDEP (Laboratory for Research & Development in Proton Therapy), further expanding expertise in the field.
“The Argentinian project has been conceived as part of a national health program to establish centers for cancer diagnosis and treatment in different regions of the country. In addition to the installation of the proton therapy system, which is already in its final phase, other tasks such as training human resources, ensuring efficient clinical operations, guaranteeing high-quality technical services, updating and upgrading the system throughout the facility’s lifecycle, and developing a research program will be challenges to undertake. These efforts will pave the way for similar projects in developing countries.”
— Alejandro Mazal, Centro de Protonterapia Quironsalud, Spain
Bridging Borders in Particle Therapy at PTCOG 63
As Latin America’s first-ever PTCOG-hosted conference, PTCOG 63 will bring together global and regional leaders to explore proton therapy, carbon ion therapy, clinical applications, and research innovations.
Key Highlights:
✔ Educational & Scientific Sessions – Gain insights from global experts on physics, clinical applications, biology, and emerging innovations in particle therapy.
✔ Keynote & Industry Symposia – Hear from thought leaders and industry pioneers on the latest advancements in cancer treatment.
✔ Oral & Poster Presentations – Explore groundbreaking research and clinical outcomes through interactive discussions.
✔ Networking & Collaboration – Connect with clinicians, researchers, and industry leaders at receptions, facility tours, and dedicated networking events.
✔ Exhibitor Lounge & Sub-Committee Sessions – Engage with leading companies and participate in focused discussions shaping the future of particle therapy.
With 4,000+ PTCOG members and 100+ facilities worldwide, this year’s conference will be a key platform for advancing innovation, collaboration, and patient access.
Join Us in Buenos Aires!
As PTCOG 63 coincides with the launch of CeArP, this is a once-in-a-lifetime opportunity to witness the dawn of proton therapy in Latin America. We invite the global particle therapy community to be part of this historic moment and help shape the future of cancer treatment in the region.
Join us in Buenos Aires from June 2–7, 2025, and be part of this historic moment.
🔗 For more information, visit https://ptcog63.org
Contact
Milush Bahanov
Global Marketing & Communication Manager